P01100 (FOS_HUMAN)
Reviewed,
UniProtKB/Swiss-Prot
Last modified
August 10, 2010.
Version 128.
History...
Names and origin
| Protein names | Recommended name: Proto-oncogene c-Fos Alternative name(s): Cellular oncogene fos G0/G1 switch regulatory protein 7 | ||||
| Gene names |
| ||||
| Organism | Homo sapiens (Human) [Complete proteome] | ||||
| Taxonomic identifier | 9606 [NCBI] | ||||
| Taxonomic lineage | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Primates › Haplorrhini › Catarrhini › Hominidae › Homo |
Protein attributes
| Sequence length | 380 AA. |
| Sequence status | Complete. |
| Protein existence | Evidence at protein level. |
General annotation (Comments)
| Function | Nuclear phosphoprotein which forms a tight but non-covalently linked complex with the JUN/AP-1 transcription factor. In the heterodimer, FOS and JUN/AP-1 basic regions each seems to interact with symmetrical DNA half sites. Has a critical function in regulating the development of cells destined to form and maintain the skeleton. It is thought to have an important role in signal transduction, cell proliferation and differentiation. Ref.9 Ref.10 |
| Subunit structure | Heterodimer with JUN. Interacts with DSIPI; this interaction inhibits the binding of active AP1 to its target DNA. Interacts with MAFB By similarity. |
| Subcellular location | |
| Post-translational modification | Phosphorylated in the C-terminal upon stimulation by nerve growth factor (NGF) and epidermal growth factor (EGF). Phosphorylated, in vitro, by MAPK and RSK1. Phosphorylation on both Ser-362 and Ser-374 by MAPK1/2 and RSK1/2 leads to protein stabilization with phosphorylation on Ser-374 being the major site for protein stabilization on NGF stimulation. Phosphorylation on Ser-362 and Ser-374 primes further phosphorylations on Thr-325 and Thr-331 through promoting docking of MAPK to the DEF domain. Phosphorylation on Thr-232, induced by HA-RAS, activates the transcriptional activity and antagonizes sumoylation. Phosphorylation on Ser-362 by RSK2 in osteoblasts contributes to osteoblast transformation By similarity. Ref.9 Constitutively sumoylated by SUMO1, SUMO2 and SUMO3. Desumoylated by SENP2. Sumoylation requires heterodimerization with JUN and is enhanced by mitogen stimulation. Sumoylation inhibits the AP-1 transcriptional activity and is, itself, inhibited by Ras-activated phosphorylation on Thr-232. Ref.10 Ref.12 |
| Sequence similarities | Belongs to the bZIP family. Fos subfamily. Contains 1 bZIP domain. |
Ontologies
| Keywords | |
|---|---|
| Cellular component | Nucleus |
| Disease | Proto-oncogene |
| Ligand | DNA-binding |
| PTM | Isopeptide bond Phosphoprotein Ubl conjugation |
| Technical term | 3D-structure Complete proteome |
| Gene Ontology (GO) | |
| Biological process | DNA methylation Traceable author statement. Source: ProtInc SMAD protein signal transductionInferred from direct assay. Source: BHF-UCL cellular response to reactive oxygen speciesInferred from direct assay. Source: BHF-UCL inflammatory responseTraceable author statement. Source: ProtInc transforming growth factor beta receptor signaling pathwayInferred from direct assay. Source: BHF-UCL |
| Molecular function | R-SMAD binding Inferred from physical interaction. Source: BHF-UCL promoter bindingInferred from direct assay. Source: BHF-UCL specific RNA polymerase II transcription factor activityTraceable author statement. Source: ProtInc transcription factor activityInferred from direct assay. Source: BHF-UCL |
| Complete GO annotation... | |
Binary interactions
With | Entry | #Exp. | IntAct | Notes |
|---|---|---|---|---|
| APP | P05067 | 1 | EBI-852851,EBI-77613 | |
| ATF2 | P15336 | 2 | EBI-852851,EBI-1170906 | |
| CLU | P10909 | 1 | EBI-852851,EBI-1104674 | |
| COPS4 | Q9BT78 | 1 | EBI-852851,EBI-742413 | |
| CUL2 | Q13617 | 1 | EBI-852851,EBI-456179 | |
| EDF1 | O60869 | 1 | EBI-852851,EBI-781301 | |
| JUN | P05412 | 2 | EBI-852851,EBI-852823 | |
| JUND | P17535 | 1 | EBI-852851,EBI-2682803 | |
| ZNF133 | P52736 | 2 | EBI-852851,EBI-2687350 |
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | ||||||||
Molecule processing | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Chain | 1 – 380 | 380 | Proto-oncogene c-Fos | PRO_0000076465 | |||||||||
Regions | |||||||||||||
| Domain | 165 – 193 | 29 | Leucine-zipper | ||||||||||
| DNA binding | 139 – 160 | 22 | Basic motif Ref.8 | ||||||||||
Amino acid modifications | |||||||||||||
| Modified residue | 232 | 1 | Phosphothreonine By similarity | ||||||||||
| Modified residue | 325 | 1 | Phosphothreonine By similarity | ||||||||||
| Modified residue | 331 | 1 | Phosphothreonine By similarity | ||||||||||
| Modified residue | 362 | 1 | Phosphoserine; by MAPK and RPS6KA3 Ref.9 | ||||||||||
| Modified residue | 374 | 1 | Phosphoserine; by MAPK Ref.9 | ||||||||||
| Cross-link | 113 | Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin) Ref.11 | |||||||||||
| Cross-link | 265 | Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO) By similarity | |||||||||||
Experimental info | |||||||||||||
| Mutagenesis | 128 | 1 | K → R: No change in sumoylation. Ref.10 | ||||||||||
| Mutagenesis | 192 | 1 | K → R: No change in sumoylation. Ref.10 | ||||||||||
| Mutagenesis | 232 | 1 | T → D: Decreased sumoylation levels. | ||||||||||
| Mutagenesis | 265 | 1 | K → R: Abolishes sumoylation. No change in nuclear location nor on protein stability. Increased AP1 transactivation activity when heterodimerized with cJUN. Ref.10 | ||||||||||
| Mutagenesis | 325 | 1 | T → D: No change in sumoylation levels. Ref.10 | ||||||||||
| Mutagenesis | 331 | 1 | T → D: No change in sumoylation levels. Ref.10 | ||||||||||
| Mutagenesis | 362 | 1 | S → A: Loss of protein stability. Reduced MOS/MAPK-mediated transforming ability; when associated with A-374. Ref.9 Ref.10 | ||||||||||
| Mutagenesis | 362 | 1 | S → D: Increased protein stability. Increased MOS/MAPK-mediated transforming ability and no change in sumoylation levels; when associated with D-374. Ref.9 Ref.10 | ||||||||||
| Mutagenesis | 374 | 1 | S → A: No change in sumoylation levels. Loss of protein stability. Reduced MOS/MAPK-mediated transforming ability; when associated with A-362. Ref.9 Ref.10 | ||||||||||
| Mutagenesis | 374 | 1 | S → D: Increased protein stability. Increased MOS/MAPK-mediated transforming ability and no change in sumoylation levels; when associated with D-362. Ref.9 Ref.10 | ||||||||||
| Sequence conflict | 133 – 144 | 12 | SPEEE…RRIRR → ISRRRREKENPK Ref.6 | ||||||||||
Secondary structure | |||||||||||||
Helix Strand Turn | |||||||||||||
| Helix | 141 – 191 | 51 | |||||||||||
| Helix | 193 – 197 | 5 | |||||||||||
Sequences
| ||||||||||||||||||
References
| « Hide 'large scale' references | |
| [1] | "Complete nucleotide sequence of a human c-onc gene: deduced amino acid sequence of the human c-fos protein." van Straaten F., Mueller R., Curran T., Van Beveren C., Verma I.M. Proc. Natl. Acad. Sci. U.S.A. 80:3183-3187(1983) [PubMed: 6574479] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA]. |
| [2] | NIEHS SNPs program Submitted (JAN-2003) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA]. |
| [3] | "The DNA sequence and analysis of human chromosome 14." Heilig R., Eckenberg R., Petit J.-L., Fonknechten N., Da Silva C., Cattolico L., Levy M., Barbe V., De Berardinis V., Ureta-Vidal A., Pelletier E., Vico V., Anthouard V., Rowen L., Madan A., Qin S., Sun H., Du H. Weissenbach J.Nature 421:601-607(2003) [PubMed: 12508121] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. |
| [4] | "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)." The MGC Project Team Genome Res. 14:2121-2127(2004) [PubMed: 15489334] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. Tissue: Pancreas. |
| [5] | "Retrovirus-mediated gene transfer of a human c-fos cDNA into mouse bone marrow stromal cells." Roux P., Verrier B., Klein B., Niccolino M., Marty L., Alexandre C., Piechaczyk M. Oncogene 6:2155-2160(1991) [PubMed: 1658710] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] OF 1-6. |
| [6] | "Transcription factor ATF cDNA clones: an extensive family of leucine zipper proteins able to selectively form DNA-binding heterodimers." Hai T., Liu F., Coukos W.J., Green M.R. Genes Dev. 3:2083-2090(1989) [PubMed: 2516827] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] OF 133-200. |
| [7] | Erratum Hai T., Liu F., Coukos W.J., Green M.R. Genes Dev. 4:682-682(1990) |
| [8] | "The basic region of Fos mediates specific DNA binding." Nakabeppu Y., Nathans D. EMBO J. 8:3833-3841(1989) [PubMed: 2511004] [Abstract] Cited for: DNA-BINDING. |
| [9] | "The Mos/MAP kinase pathway stabilizes c-Fos by phosphorylation and augments its transforming activity in NIH 3T3 cells." Okazaki K., Sagata N. EMBO J. 14:5048-5059(1995) [PubMed: 7588633] [Abstract] Cited for: PHOSPHORYLATION AT SER-362 AND SER-374, FUNCTION, MUTAGENESIS OF SER-362 AND SER-374. |
| [10] | "Down-regulation of c-Fos/c-Jun AP-1 dimer activity by sumoylation." Bossis G., Malnou C.E., Farras R., Andermarcher E., Hipskind R., Rodriguez M., Schmidt D., Muller S., Jariel-Encontre I., Piechaczyk M. Mol. Cell. Biol. 25:6964-6979(2005) [PubMed: 16055710] [Abstract] Cited for: SUMOYLATION AT LYS-265, SUBCELLULAR LOCATION, FUNCTION, MUTAGENESIS OF LYS-128; LYS-192; LYS-265; THR-325; THR-331; SER-362 AND SER-374. |
| [11] | "The proteomic reactor facilitates the analysis of affinity-purified proteins by mass spectrometry: application for identifying ubiquitinated proteins in human cells." Vasilescu J., Zweitzig D.R., Denis N.J., Smith J.C., Ethier M., Haines D.S., Figeys D. J. Proteome Res. 6:298-305(2007) [PubMed: 17203973] [Abstract] Cited for: UBIQUITINATION [LARGE SCALE ANALYSIS] AT LYS-113, MASS SPECTROMETRY. Tissue: Lung adenocarcinoma. |
| [12] | "Ubc9 fusion-directed SUMOylation identifies constitutive and inducible SUMOylation." Jakobs A., Himstedt F., Funk M., Korn B., Gaestel M., Niedenthal R. Nucleic Acids Res. 35:E109-E109(2007) [PubMed: 17709345] [Abstract] Cited for: SUMOYLATION. |
| [13] | "Crystal structure of the heterodimeric bZIP transcription factor c-Fos-c-Jun bound to DNA." Glover J.N., Harrison S.C. Nature 373:257-261(1995) [PubMed: 7816143] [Abstract] Cited for: X-RAY CRYSTALLOGRAPHY (3.05 ANGSTROMS) OF 139-198 OF COMPLEX WITH JUN. |
| + | Additional computationally mapped references. |
Web resources
Cross-references
Sequence databases | |||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EMBL GenBank DDBJ | V01512 Genomic DNA. Translation: CAA24756.1. K00650 Genomic DNA. Translation: AAA52471.1. AY212879 Genomic DNA. Translation: AAO21129.1. AF111167 Genomic DNA. Translation: AAC98315.1. BC004490 mRNA. Translation: AAH04490.1. S65138 mRNA. Translation: AAB20306.1. | ||||||||||||||||||||||||
| IPI | IPI00033008. | ||||||||||||||||||||||||
| PIR | TVHUF1. A01342. E34223. | ||||||||||||||||||||||||
| RefSeq | NP_005243.1. | ||||||||||||||||||||||||
| UniGene | Hs.25647. | ||||||||||||||||||||||||
3D structure databases | |||||||||||||||||||||||||
| PDBe RCSB PDB PDBj |
| ||||||||||||||||||||||||
| ProteinModelPortal | P01100. | ||||||||||||||||||||||||
| DisProt | DP00078. | ||||||||||||||||||||||||
| ModBase | Search... | ||||||||||||||||||||||||
Protein-protein interaction databases | |||||||||||||||||||||||||
| DIP | DIP-1047N. | ||||||||||||||||||||||||
| IntAct | P01100. 95 interactions. | ||||||||||||||||||||||||
| MINT | MINT-105814. | ||||||||||||||||||||||||
| STRING | P01100. | ||||||||||||||||||||||||
PTM databases | |||||||||||||||||||||||||
| PhosphoSite | P01100. | ||||||||||||||||||||||||
Proteomic databases | |||||||||||||||||||||||||
| PRIDE | P01100. | ||||||||||||||||||||||||
Genome annotation databases | |||||||||||||||||||||||||
| Ensembl | ENST00000303562; ENSP00000306245; ENSG00000170345; Homo sapiens. [Genome view] | ||||||||||||||||||||||||
| GeneID | 2353. | ||||||||||||||||||||||||
| KEGG | hsa:2353. | ||||||||||||||||||||||||
| UCSC | uc001xrn.1. human. | ||||||||||||||||||||||||
Organism-specific databases | |||||||||||||||||||||||||
| CTD | 2353. | ||||||||||||||||||||||||
| GeneCards | GC14P075745. | ||||||||||||||||||||||||
| H-InvDB | HIX0011826. | ||||||||||||||||||||||||
| HGNC | HGNC:3796. FOS. | ||||||||||||||||||||||||
| HPA | HPA018531. | ||||||||||||||||||||||||
| MIM | 164810. gene. | ||||||||||||||||||||||||
| PharmGKB | PA134953249. | ||||||||||||||||||||||||
| GenAtlas | Search... | ||||||||||||||||||||||||
Phylogenomic databases | |||||||||||||||||||||||||
| eggNOG | prNOG06597. | ||||||||||||||||||||||||
| HOGENOM | HBG714812. | ||||||||||||||||||||||||
| HOVERGEN | HBG005743. | ||||||||||||||||||||||||
| InParanoid | P01100. | ||||||||||||||||||||||||
| OMA | DWEPLHG. | ||||||||||||||||||||||||
| OrthoDB | EOG91RSDG. | ||||||||||||||||||||||||
| PhylomeDB | P01100. | ||||||||||||||||||||||||
Enzyme and pathway databases | |||||||||||||||||||||||||
| Pathway_Interaction_DB | bcr_5pathway. BCR signaling pathway. nfat_tfpathway. Calcineurin-regulated NFAT-dependent transcription in lymphocytes. tcrcalciumpathway. Calcium signaling in the CD4+ TCR pathway. cd8tcrdownstreampathway. Downstream signaling in naive CD8+ T cells. endothelinpathway. Endothelins. fcer1pathway. Fc-epsilon receptor I signaling in mast cells. fgf_pathway. FGF signaling pathway. hnf3apathway. FOXA1 transcription factor network. foxm1pathway. FOXM1 transcription factor network. hif1_tfpathway. HIF-1-alpha transcription factor network. il12_stat4pathway. IL12 signaling mediated by STAT4. il12_2pathway. IL12-mediated signaling events. il2_1pathway. IL2-mediated signaling events. il6_7pathway. IL6-mediated signaling events. lysophospholipid_pathway. LPA receptor mediated events. avb3_opn_pathway. Osteopontin-mediated events. pdgfrapathway. PDGFR-alpha signaling pathway. ps1pathway. Presenilin action in Notch and Wnt signaling. tcrraspathway. Ras signaling in the CD4+ TCR pathway. smad2_3nuclearpathway. Regulation of nuclear SMAD2/3 signaling. telomerasepathway. Regulation of Telomerase. s1p_s1p2_pathway. S1P2 pathway. met_pathway. Signaling events activated by Hepatocyte Growth Factor Receptor (c-Met). mapktrkpathway. Trk receptor signaling mediated by the MAPK pathway. | ||||||||||||||||||||||||
| Reactome | REACT_6900. Signaling in Immune system. | ||||||||||||||||||||||||
Gene expression databases | |||||||||||||||||||||||||
| ArrayExpress | P01100. | ||||||||||||||||||||||||
| Bgee | P01100. | ||||||||||||||||||||||||
| CleanEx | HS_FOS. | ||||||||||||||||||||||||
| Genevestigator | P01100. | ||||||||||||||||||||||||
| GermOnline | ENSG00000170345. Homo sapiens. | ||||||||||||||||||||||||
Family and domain databases | |||||||||||||||||||||||||
| InterPro | IPR011616. bZIP_1. IPR000837. Leuzip_Fos. IPR004827. TF_bZIP. [Graphical view] | ||||||||||||||||||||||||
| Pfam | PF00170. bZIP_1. 1 hit. [Graphical view] | ||||||||||||||||||||||||
| PRINTS | PR00042. LEUZIPPRFOS. | ||||||||||||||||||||||||
| SMART | SM00338. BRLZ. 1 hit. [Graphical view] | ||||||||||||||||||||||||
| PROSITE | PS50217. BZIP. 1 hit. PS00036. BZIP_BASIC. 1 hit. [Graphical view] | ||||||||||||||||||||||||
| ProtoNet | Search... | ||||||||||||||||||||||||
Other Resources | |||||||||||||||||||||||||
| NextBio | 9543. | ||||||||||||||||||||||||
| SOURCE | Search... | ||||||||||||||||||||||||
Entry information
| Entry name | FOS_HUMAN | ||||||||
| Accession | Primary (citable) accession number: P01100 Secondary accession number(s): P18849 | ||||||||
| Entry history |
| ||||||||
| Entry status | Reviewed (UniProtKB/Swiss-Prot) | ||||||||
| Annotation project | HPI (Human Proteome Initiative) | ||||||||
| Disclaimer | Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. It is not in any way intended to be used as a substitute for professional medical advice, diagnosis, treatment or care. | ||||||||
Relevant documents
| Human chromosome 14 Human chromosome 14: entries, gene names and cross-references to MIM |
| MIM cross-references Online Mendelian Inheritance in Man (MIM) cross-references in UniProtKB/Swiss-Prot |
| PDB cross-references Index of Protein Data Bank (PDB) cross-references |
| SIMILARITY comments Index of protein domains and families |

Clusters with


